PCA Administration in Prosthetic Joint Infection
ConditionProsthetic Joint Infection
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorDr. Dean Reeves Clinic
About this trial
Determine if dietary protocatechuic acid (PCA) will affect health biomarkers in patient undergoing revision surgery for a knee prosthetic joint infection
Eligibility criteria
Qualifiers
3 weeks or more after total knee arthroplasty
One or more symptoms of infection, including redness, swelling, pain, increasing range of motion loss, fever, nausea, and loss of appetite.
WBC count of aspirate >50,000 cells per μL
Disqualifiers
Not willing to undergo blood draw at 3 months.
Trial design
Treatments tested in this trial
- Oral PCA
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov